Xingmei Yao
164 LanXi Road
Shanghai, 200062, China
Shanghai, 200062, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Upregulation of PTPRO by WT1 alleviates podocyte injury in diabetic nephropathy through inhibiting the c-Abl/p53 pathway.
Journal: Cellular and molecular life sciences : CMLS
Published: March 26, 2026
Differences and significance of macrophage subtypes and regulatory T lymphocytes in the expression of interstitial fibrosis in diabetic nephropathy at different stages.
Journal: BMC nephrology
Published: March 05, 2025
Canagliflozin Attenuates Podocyte Inflammatory Injury through Suppressing the TXNIP/NLRP3 Signaling Pathway in Diabetic Kidney Disease Mice.
Journal: Inflammation
Published: October 20, 2024
Astragaloside IV attenuates podocyte apoptosis through ameliorating mitochondrial dysfunction by up-regulated Nrf2-ARE/TFAM signaling in diabetic kidney disease.
Journal: Free radical biology & medicine
Published: January 03, 2023
Astragaloside IV attenuates high glucose-induced NF-κB-mediated inflammation through activation of PI3K/AKT-ERK-dependent Nrf2/ARE signaling pathway in glomerular mesangial cells.
Journal: Phytotherapy research : PTR
Published: November 28, 2022
Klotho Ameliorates Podocyte Injury through Targeting TRPC6 Channel in Diabetic Nephropathy.
Journal: Journal of diabetes research
Published: October 18, 2021
Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
Journal: Biochemical and biophysical research communications
Published: October 17, 2020
Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
Journal: Life sciences
Published: August 03, 2020
ApoL1 induces kidney inflammation through RIG-I/NF-κB activation.
Journal: Biochemical and biophysical research communications
Published: March 25, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026